Filter
1763
Filtered Results: 1763
Text search:
World
Health
Organization
WHO
and
World
Intellectual
Property
Organization
Featured
Recommendations
216
New Publications
374
Language
Document type
No document type
641
Studies & Reports
385
Guidelines
342
Manuals
192
Strategic & Response Plan
110
Training Material
51
Fact sheets
28
Situation Updates
7
Resource Platforms
4
Infographics
3
Countries / Regions
Global
143
India
33
Africa
28
South–East Asia Region
27
Western and Central Europe
27
Ukraine
26
Uganda
23
Kenya
22
Ethiopia
20
South Africa
19
Nepal
16
Eastern Europe and Central Asia
16
Ghana
15
Asia
14
Nigeria
13
Myanmar / Burma
13
West and Central Africa
13
Bangladesh
12
East and Southern Africa
12
Sierra Leone
11
Liberia
11
Zambia
11
Syria
11
Indonesia
11
Malawi
11
Tanzania
10
Cambodia
10
Rwanda
9
Middle East and North Africa
9
Western Pacific Region
9
South Sudan
7
Yemen
7
Philippines
6
Afghanistan
6
Lesotho
6
Eastern Europe
6
Guinea
5
Congo, Democratic Republic of
5
Cameroon
5
Zimbabwe
5
Somalia
5
Pakistan
5
Thailand
5
Mozambique
5
Latin America and the Carribbean
5
Haiti
4
Sudan
4
Russia
4
Vietnam
4
Burkina Faso
3
Germany
3
Lebanon
3
North Macedonia
3
Laos
3
Tajikistan
3
Iran
3
Côte d’Ivoire / Ivory Coast
2
Saudi Arabia
2
Iraq
2
Jordan
2
China
2
Peru
2
Colombia
2
Ecuador
2
Botswana
2
Angola
2
Sri Lanka
2
Venezuela
2
Palestine
2
Djibouti
2
Timor Leste/ East Timor
2
Lithuania
2
Kyrgyzstan
2
Kazakhstan
2
Georgia
2
Senegal
1
Mali
1
Morocco
1
USA
1
Turkey
1
Egypt
1
Chad
1
Papua New Guinea
1
Namibia
1
Eswatini/ Swaziland
1
Brazil
1
Serbia
1
Bolivia
1
Greece
1
Libya
1
Mexico
1
Chile
1
Paraguay
1
Bhutan
1
North Korea
1
Albania
1
Armenia
1
Mongolia
1
Canada
1
Qatar
1
Bulgaria
1
Estonia
1
Uzbekistan
1
Japan
1
Denmark
1
Mauritius
1
Tunisia
1
Azerbaijan
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
344
Clinical Guidelines
224
Public Health
167
Women & Child Health
131
Key Resources
111
Capacity Building
53
Pharmacy & Technologies
43
Toolboxes
Mental Health
176
COVID-19
148
HIV
140
Disability
137
TB
97
Caregiver
86
Planetary Health
85
AMR
70
Rapid Response
65
NTDs
63
Global Health Education
56
Conflict
42
Pharmacy
42
NCDs
42
Health Financing Toolbox
20
Refugee
19
Ebola
16
Specific Hazards
10
Natural Hazards
9
Social Ethics
8
Polio
6
Zika
4
Cholera
3
Despite the development of point-of-care diagnostic tests for syphilis, chlamydia, gonorrhoea, and trichomoniasis, none comply with all WHO criteria. This analysis overviews landscape analyses of po...
This publication aims to provide updated guidance on the specific use of yellow fever laboratory assays in the context of surveillance to be used across the Global Yellow Fever Laboratory Network for disease surveillance. In the recent years, new commercial assays became available ... are now recommended for use by WHO and this publication will support national program on the use of compound laboratory assays as per the most recent recommended testing algorithms. This piece is aligned with the elimination effort set in the comprehensive global strategy to eliminate yellow fever epidemics (EYE) strategy 2017-2026 and where its advisory laboratory technical working group actively contributed to its development. The target audiences are policy-makers and health workers.
WHO has published the first-ever guidance on the clinical management of diphtheria. The only previously available guidance was an operational protocol. The new guidance followed the rigorous process for developing guidance at ....
It addresses the use of Diphtheria Antitoxin (DAT) in the treatment of diphtheria. There is a worldwide shortage of DAT and evidence based recommendations on the use of DAT were requested by many Member States.
The guidance also includes new recommendations on antibiotics. In patients with suspected or confirmed diphtheria, WHO recommends using macrolide antibiotics (azithromycin, erythromycin) rather than penicillin antibiotics.
This clinical practice guideline has been rapidly developed recognizing the global increase in diphtheria outbreaks. Outbreaks of diphtheria in Nigeria, Guinea and neighbouring countries in 2023 have highlighted the urgent need for evidence-based clinical practice guidelines for the treatment of diphtheria. Given the sporadic nature of outbreaks, many clinicians in the affected regions have never managed acute diphtheria and its related complications. Diphtheria remains a neglected disease and vaccination is the top priority. At the same time, for patients with diphtheria, access to antibiotics, DAT and supportive care can be lifesaving.
Evidence-based psychological interventions are an important part of health, social, protection and education services and can help increase access ...
This Birth Defect Surveillance facilitator (train-the-trainer) guide 2nd edition covers foundational skills needed to begin the development, implementation and ongoing improvement of a congenital anomaly surveillance programme, whether population-ba...
Long-lasting insecticidal nets (LNs) constitute a core vector control intervention against malaria. A number of new LN products are under development and will require assessment of risks to humans. This document provides an updated generic model tha...
The recommendations cover the level of blood pressure to start medication, what type of medicine or combination of medicines to use, the target blood pressure level, and how often to have follow-up checks on blood pressure. In addition, the guidelin...
31 Oct 2022 his plan outlines how the ACT-Accelerator will support countries as the world transitions to long-term COVID-19 control.
Recognizing the evolving nature of the COVID-19 virus and...
A framework for action provides a guide for those involved in the development of the multisectoral action plan. It starts with a wide-ranging vision and, through a series of increasingly specific intentions, brings into focus actions with measurable...
Technical Update
Areas of Africa endemic for Buruli ulcer (BU), caused by Mycobacterium ulcerans, also have a high prevalence of human immunodeficiency virus (HIV), with adult prevalence rates between 1% and 5% (Maps). However, there is limited inf...
This user guide is designed to provide national malaria control programmes with general information on glucose-6-phosphate dehydrogenase (G6PD) deficiency. Individuals with this condition may be at risk of adverse effects from medicines commonly used to cure Plasmodium vivax malaria, as well as from...
This manual will aid in building the capacity of nurses with clinical knowledge of the unique needs, complex health problems, common geriatric syndromes, and principles of care of older people. It w...
These country profiles present progress on implementation of policy recommendations of the Global Action Plan on Physical Activity (GAPPA) 2018-2030 in each country. They also present an estimate of the cost to health systems of not taking action t...
One of the first steps in developing a multisectoral action plan (MSAP) is to use a situation analysis to provide a comprehensive assessment of the health needs, prevailing risks and the context of...
This publication provides directions for a logical, evidence informed approach to selecting, developing, implementing and monitoring population-based interventions within the context of the double-burden of malnutrition in South-East Asia. The focus...
The WHO Guidance for Conducting a Country COVID-19 Intra-Action Review (IAR) was developed to guide countries to conduct periodic review(s) of their national and subnational COVID-19 response, so co...
This report presents key findings from a study carried out on the ‘Mainstreaming quality of care in empanelled hospitals under PMJAY’. It provides a detailed analysis of current coverage and perceptions of quality accreditation ... certification across PMJAY empanelled hospitals from three different states
(Haryana, Uttar Pradesh and Gujarat).
This document summarizes the results of the WHO-commissioned full value proposition for new tuberculosis (TB) vaccines. The assessment was commissioned to provide early evidence for national and glo...
Trachoma is the leading infectious cause of blindness (2). It is characterized by repeated
conjunctival infection with particular strains of Chlamydia trachomatis. This scars the conjunctivae and,
in some cases, leads to trichiasis with or without...
This document provides interim guidance to countries on testing considerations and strategies for suspect cases of severe acute hepatitis of unknown aetiology in children. It is primarily intended for clinical, programmatic, laboratory ... diagnostic stakeholders across Member States and national public health authorities involved in the identification and investigation of cases of severe acute hepatitis in children.
This document is part of a package of guidance for this event, which includes suggested minimum reporting variables and a clinical Case Report Form support Member States with case investigation and reporting.
